Literature DB >> 20035081

The C terminus of cardiac troponin I stabilizes the Ca2+-activated state of tropomyosin on actin filaments.

Agnieszka Galińska1, Victoria Hatch, Roger Craig, Anne M Murphy, Jennifer E Van Eyk, C-L Albert Wang, William Lehman, D Brian Foster.   

Abstract

RATIONALE: Ca(2+) control of troponin-tropomyosin position on actin regulates cardiac muscle contraction. The inhibitory subunit of troponin, cardiac troponin (cTn)I is primarily responsible for maintaining a tropomyosin conformation that prevents crossbridge cycling. Despite extensive characterization of cTnI, the precise role of its C-terminal domain (residues 193 to 210) is unclear. Mutations within this region are associated with restrictive cardiomyopathy, and C-terminal deletion of cTnI, in some species, has been associated with myocardial stunning.
OBJECTIVE: We sought to investigate the effect of a cTnI deletion-removal of 17 amino acids from the C terminus- on the structure of troponin-regulated tropomyosin bound to actin. METHODS AND
RESULTS: A truncated form of human cTnI (cTnI(1-192)) was expressed and reconstituted with troponin C and troponin T to form a mutant troponin. Using electron microscopy and 3D image reconstruction, we show that the mutant troponin perturbs the positional equilibrium dynamics of tropomyosin in the presence of Ca(2+). Specifically, it biases tropomyosin position toward an "enhanced C-state" that exposes more of the myosin-binding site on actin than found with wild-type troponin.
CONCLUSIONS: In addition to its well-established role of promoting the so-called "blocked-state" or "B-state," cTnI participates in proper stabilization of tropomyosin in the "Ca(2+)-activated state" or "C-state." The last 17 amino acids perform this stabilizing role. The data are consistent with a "fly-casting" model in which the mobile C terminus of cTnI ensures proper conformational switching of troponin-tropomyosin. Loss of actin-sensing function within this domain, by pathological proteolysis or cardiomyopathic mutation, may be sufficient to perturb tropomyosin conformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035081      PMCID: PMC2834238          DOI: 10.1161/CIRCRESAHA.109.210047

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  45 in total

1.  A robust algorithm for the reconstruction of helical filaments using single-particle methods.

Authors:  E H Egelman
Journal:  Ultramicroscopy       Date:  2000-12       Impact factor: 2.689

2.  Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments.

Authors:  W Lehman; V Hatch; V Korman; M Rosol; L Thomas; R Maytum; M A Geeves; J E Van Eyk; L S Tobacman; R Craig
Journal:  J Mol Biol       Date:  2000-09-22       Impact factor: 5.469

3.  Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form.

Authors:  Soichi Takeda; Atsuko Yamashita; Kayo Maeda; Yuichiro Maéda
Journal:  Nature       Date:  2003-07-03       Impact factor: 49.962

4.  Transgenic mouse model of stunned myocardium.

Authors:  A M Murphy; H Kögler; D Georgakopoulos; J L McDonough; D A Kass; J E Van Eyk; E Marbán
Journal:  Science       Date:  2000-01-21       Impact factor: 47.728

Review 5.  Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.

Authors:  R A Kloner; R B Jennings
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

6.  Cardiac troponin I is modified in the myocardium of bypass patients.

Authors:  J L McDonough; R Labugger; W Pickett; M Y Tse; S MacKenzie; S C Pang; D Atar; G Ropchan; J E Van Eyk
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

7.  Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.

Authors:  Jens Mogensen; Toru Kubo; Mauricio Duque; William Uribe; Anthony Shaw; Ross Murphy; Juan R Gimeno; Perry Elliott; William J McKenna
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

8.  Familial hypertrophic cardiomyopathy mutations in troponin I (K183D, G203S, K206Q) enhance filament sliding.

Authors:  Jan Köhler; Ying Chen; Bernhard Brenner; Albert M Gordon; Theresia Kraft; Donald A Martyn; Michael Regnier; Anthony J Rivera; Chien-Kao Wang; P Bryant Chase
Journal:  Physiol Genomics       Date:  2003-07-07       Impact factor: 3.107

9.  Structural basis for the activation of muscle contraction by troponin and tropomyosin.

Authors:  William Lehman; Agnieszka Galińska-Rakoczy; Victoria Hatch; Larry S Tobacman; Roger Craig
Journal:  J Mol Biol       Date:  2009-03-31       Impact factor: 5.469

10.  Actin depolymerizing factor stabilizes an existing state of F-actin and can change the tilt of F-actin subunits.

Authors:  V E Galkin; A Orlova; N Lukoyanova; W Wriggers; E H Egelman
Journal:  J Cell Biol       Date:  2001-04-02       Impact factor: 10.539

View more
  40 in total

1.  Dual regulatory functions of the thin filament revealed by replacement of the troponin I inhibitory peptide with a linker.

Authors:  Julie Mouannes Kozaili; Daniel Leek; Larry S Tobacman
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

2.  Low temperature dynamic mapping reveals unexpected order and disorder in troponin.

Authors:  Devanand Kowlessur; Larry S Tobacman
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

3.  The functional significance of the last 5 residues of the C-terminus of cardiac troponin I.

Authors:  Jennifer E Gilda; Qian Xu; Margaret E Martinez; Susan T Nguyen; P Bryant Chase; Aldrin V Gomes
Journal:  Arch Biochem Biophys       Date:  2016-02-23       Impact factor: 4.013

4.  Functional significance of C-terminal mobile domain of cardiac troponin I.

Authors:  Nazanin Bohlooli Ghashghaee; Bertrand C W Tanner; Wen-Ji Dong
Journal:  Arch Biochem Biophys       Date:  2017-09-27       Impact factor: 4.013

5.  Structural dynamics of C-domain of cardiac troponin I protein in reconstituted thin filament.

Authors:  Zhiqun Zhou; King-Lun Li; Daniel Rieck; Yexin Ouyang; Murali Chandra; Wen-Ji Dong
Journal:  J Biol Chem       Date:  2011-12-28       Impact factor: 5.157

6.  Atomic resolution probe for allostery in the regulatory thin filament.

Authors:  Michael R Williams; Sarah J Lehman; Jil C Tardiff; Steven D Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-08       Impact factor: 11.205

7.  Structural and kinetic effects of hypertrophic cardiomyopathy related mutations R146G/Q and R163W on the regulatory switching activity of rat cardiac troponin I.

Authors:  Zhiqun Zhou; Daniel Rieck; King-Lun Li; Yexin Ouyang; Wen-Ji Dong
Journal:  Arch Biochem Biophys       Date:  2012-12-13       Impact factor: 4.013

8.  Significance of troponin dynamics for Ca2+-mediated regulation of contraction and inherited cardiomyopathy.

Authors:  Devanand Kowlessur; Larry S Tobacman
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

9.  Role of cardiac troponin I carboxy terminal mobile domain and linker sequence in regulating cardiac contraction.

Authors:  Nancy L Meyer; P Bryant Chase
Journal:  Arch Biochem Biophys       Date:  2016-03-10       Impact factor: 4.013

10.  Conformation and Dynamics of the Troponin I C-Terminal Domain: Combining Single-Molecule and Computational Approaches for a Disordered Protein Region.

Authors:  Lauren Ann Metskas; Elizabeth Rhoades
Journal:  J Am Chem Soc       Date:  2015-09-10       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.